29 Sep Launch of COVID-19 antibody test
Paris, France and Camberley, UK – 29 September 2020 – Novacyt, an international specialist in clinical diagnostics, announces that, further to the announcement on 27 July 2020, the Company has...
28 Sep Appointment of ODDO BHF
Paris, France and Camberley, UK – 28 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the appointment of ODDO BHF, an independent...
18 Sep AGM voting
Paris, France and Camberley, UK – 18 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM)...
17 Sep Half year 2020 results
[vc_row][vc_column][vc_column_text] Transformational performance set to continue Paris, France and Camberley, UK – 17 September 2020 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for...
16 Sep Appointment of Joint Broker
Paris, France and Camberley, UK – 16 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of Numis...
04 Sep Launch of two gene COVID-19 test
Paris, France and Camberley, UK – 4 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that, further to the announcement on 27...
27 Aug Launch of respiratory test panel
New test differentiates COVID-19 from common winter diseases Paris, France and Camberley, UK – 27 August 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces...
19 Aug Notice of AGM
Paris, France and Camberley, UK – 19 August 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its Annual General Meeting (AGM) will...
27 Jul R&D Update
Significant new opportunities for growth Paris, France and Camberley, UK – 27 July 2020 – Novacyt (EURONEXT GROWTH:ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an R&Dupdate. https://novacyt.com/wp-content/uploads/2020/07/Novacyt-RD-Update-27-07-20-ENGLISH.pdf ...
22 Jul 2,000 patient clinical trial using Novacyt’s nearpatient testing system initiated in London care homes
Posted at 15:40h
in Novacyt Group
Paris, France and Camberley, UK – 22 July 2020 – Novacyt (EURONEXT GROWTH:ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, notes the initiationof a clinical trial by Queen Mary...